Trials / Completed
CompletedNCT05473585
Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate how limiting the nicotine content in regular cigarettes affects choices for regular cigarette and e-cigarette products. Eligible participants will be of legal age to purchase tobacco products and regularly use both e-cigarettes and regular cigarettes.
Detailed description
Participants in this study will undergo an in-person screening session where the study will be explained in detail and participants will answer questions and provide a breath sample. During the screening session, participants will also be asked to complete surveys. Eligible participants will then complete the training procedures during which they will select an e-cigarette device to use for future preference sessions. During the 4 preference sessions, participants will sample puffs from an e-cigarette and regular cigarette and answer questions about their experience with each. They will also complete a task during which they can choose to earn puffs from the e-cigarette or regular cigarette, or choose to not take any puffs. The 4 sessions will be the same except that a different combination of e-cigarette and regular cigarette is used at each session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | very low nicotine content cigarettes | Investigational combusted cigarettes with very low nicotine content |
| OTHER | normal nicotine content cigarettes | Investigational combusted cigarettes with normal nicotine content |
| OTHER | Study e-cigarette | E-cigarette provided by study |
Timeline
- Start date
- 2022-10-12
- Primary completion
- 2023-05-09
- Completion
- 2023-05-09
- First posted
- 2022-07-26
- Last updated
- 2023-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05473585. Inclusion in this directory is not an endorsement.